Aprepitant 125mg-80mg

What Is Aprepitant 125mg / 80mg

Aprepitant 125mg-80mg is a prescription anti-nausea medicine used to prevent chemotherapy-induced nausea and vomiting (CINV). It is usually given as a short course in a specific dosing schedule around chemotherapy treatment.

The active ingredient is Aprepitant, which belongs to a group of medicines called NK1 receptor antagonists. These medicines help control nausea signals in the brain.

Doctors, especially oncologists (cancer specialists), prescribe this medicine to patients receiving chemotherapy that is known to cause strong nausea and vomiting.

This regimen (125mg followed by 80mg doses) is designed to provide protection during the most critical days of chemotherapy-related nausea.

What This Medicine Does in the Body

Aprepitant 125mg / 80mg works by controlling nausea signals in the brain.

Chemotherapy drugs can trigger the release of a chemical called substance P. This chemical activates the brain’s vomiting center, leading to nausea and vomiting.

Aprepitant blocks a receptor called the NK1 (neurokinin-1) receptor, which is the main target of substance P.

When this receptor is blocked, the nausea signal cannot fully activate in the brain. This helps reduce or prevent vomiting.

It works along with other anti-nausea medicines to provide stronger protection during chemotherapy.

Because it acts in the central nervous system (brain), it helps control both early and delayed phases of nausea.

Uses of Aprepitant 125mg / 80mg / Used For

Aprepitant is mainly used for preventing chemotherapy-induced nausea and vomiting (CINV).

It is given to patients receiving highly or moderately emetogenic chemotherapy, meaning cancer treatments that are likely to cause strong nausea.

It is often used as part of a combination antiemetic therapy, along with other medicines like corticosteroids and serotonin blockers.

In some cases, it may also be used for post-operative nausea and vomiting (PONV) in patients undergoing surgery, depending on medical advice.

This medicine is not used for everyday nausea caused by minor stomach issues or infections. It is specifically designed for treatment-related nausea control.

How Aprepitant 125mg / 80mg Work

Aprepitant works by blocking the action of substance P, a key chemical involved in triggering vomiting.

Substance P binds to NK1 receptors in the brain, which are responsible for sending nausea and vomiting signals.

When chemotherapy is given, it increases substance P levels, which strongly activates these receptors.

Aprepitant blocks these NK1 receptors, preventing substance P from attaching to them. This stops or reduces the vomiting signal.

The treatment schedule (125mg first dose followed by 80mg doses) is designed to maintain steady protection during the chemotherapy cycle.

It works best when combined with other anti-nausea medicines, giving a multi-level control of vomiting pathways.

Side Effects of Aprepitant 125mg / 80mg

Aprepitant is generally well tolerated, but some side effects may occur in certain patients.

Common side effects include tiredness, hiccups, constipation, or mild stomach discomfort.

Some people may experience loss of appetite or mild dizziness.

Less commonly, headache or mild changes in liver enzyme levels may occur.

Rare but serious side effects include allergic reactions such as rash, swelling, or difficulty breathing. These require immediate medical attention.

Since it is used in cancer treatment settings, it is usually monitored closely by an oncologist along with other supportive medicines.

Medical Disclaimer

This content is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult an oncologist or qualified healthcare professional before using Aprepitant 125mg / 80mg. Use this medicine only under proper medical supervision.